These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 25348530)

  • 1. Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2.
    Zhao X; Guo F; Comunale MA; Mehta A; Sehgal M; Jain P; Cuconati A; Lin H; Block TM; Chang J; Guo JT
    Antimicrob Agents Chemother; 2015 Jan; 59(1):206-16. PubMed ID: 25348530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
    Rowland R; Brandariz-Nuñez A
    Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions.
    Chang J; Block TM; Guo JT
    Antiviral Res; 2013 Sep; 99(3):251-60. PubMed ID: 23816430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2.
    Li W; Sui J; Huang IC; Kuhn JH; Radoshitzky SR; Marasco WA; Choe H; Farzan M
    Virology; 2007 Oct; 367(2):367-74. PubMed ID: 17631932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.
    Struck AW; Axmann M; Pfefferle S; Drosten C; Meyer B
    Antiviral Res; 2012 Jun; 94(3):288-96. PubMed ID: 22265858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.
    Haga S; Nagata N; Okamura T; Yamamoto N; Sata T; Yamamoto N; Sasazuki T; Ishizaka Y
    Antiviral Res; 2010 Mar; 85(3):551-5. PubMed ID: 19995578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.
    Glowacka I; Bertram S; Herzog P; Pfefferle S; Steffen I; Muench MO; Simmons G; Hofmann H; Kuri T; Weber F; Eichler J; Drosten C; Pöhlmann S
    J Virol; 2010 Jan; 84(2):1198-205. PubMed ID: 19864379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iminosugars Inhibit Dengue Virus Production via Inhibition of ER Alpha-Glucosidases--Not Glycolipid Processing Enzymes.
    Sayce AC; Alonzi DS; Killingbeck SS; Tyrrell BE; Hill ML; Caputo AT; Iwaki R; Kinami K; Ide D; Kiappes JL; Beatty PR; Kato A; Harris E; Dwek RA; Miller JL; Zitzmann N
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004524. PubMed ID: 26974655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.
    Hofmann H; Pyrc K; van der Hoek L; Geier M; Berkhout B; Pöhlmann S
    Proc Natl Acad Sci U S A; 2005 May; 102(22):7988-93. PubMed ID: 15897467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
    Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
    J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry.
    Haga S; Yamamoto N; Nakai-Murakami C; Osawa Y; Tokunaga K; Sata T; Yamamoto N; Sasazuki T; Ishizaka Y
    Proc Natl Acad Sci U S A; 2008 Jun; 105(22):7809-14. PubMed ID: 18490652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors.
    Hofmann H; Simmons G; Rennekamp AJ; Chaipan C; Gramberg T; Heck E; Geier M; Wegele A; Marzi A; Bates P; Pöhlmann S
    J Virol; 2006 Sep; 80(17):8639-52. PubMed ID: 16912312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
    Kuhn JH; Li W; Radoshitzky SR; Choe H; Farzan M
    Antivir Ther; 2007; 12(4 Pt B):639-50. PubMed ID: 17944271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a new region of SARS-CoV S protein critical for viral entry.
    Guo Y; Tisoncik J; McReynolds S; Farzan M; Prabhakar BS; Gallagher T; Rong L; Caffrey M
    J Mol Biol; 2009 Dec; 394(4):600-5. PubMed ID: 19853613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of severe acute respiratory syndrome-coronavirus and NL63 coronavirus spike proteins with angiotensin converting enzyme-2.
    Mathewson AC; Bishop A; Yao Y; Kemp F; Ren J; Chen H; Xu X; Berkhout B; van der Hoek L; Jones IM
    J Gen Virol; 2008 Nov; 89(Pt 11):2741-2745. PubMed ID: 18931070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
    Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
    Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide S4 is an entry inhibitor of SARS-CoV-2 infection.
    Liang Z; Wang J; Zhang H; Gao L; Xu J; Li P; Yang J; Fu X; Duan H; Liu J; Liu T; Ma W; Wu K
    Virology; 2024 Sep; 597():110149. PubMed ID: 38917689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iminosugar antivirals: the therapeutic sweet spot.
    Alonzi DS; Scott KA; Dwek RA; Zitzmann N
    Biochem Soc Trans; 2017 Apr; 45(2):571-582. PubMed ID: 28408497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction.
    Lin HX; Feng Y; Wong G; Wang L; Li B; Zhao X; Li Y; Smaill F; Zhang C
    J Gen Virol; 2008 Apr; 89(Pt 4):1015-1024. PubMed ID: 18343844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.